Gamida Cell Receives Buyout Offer That Could Reach Hundreds of Millions of Dollars

Sources say Swiss drugmaker Novartis made the bid for the Israeli startup that specializes in stem cell medical technology.

comments Print
Gamida Cell, a stem cell medical technology startup, has received a buyout offer from an unidentified “global” pharmaceutical company that could reach into the hundreds of millions of dollars, Gamida Cell’s...